一种轮腿结合式步行机的步态

提出用周期函数G(X)和正函数H(X)表达步行机的支撑点位置。解决了在一个步态周期内轮子作多周期运动的动态支撑点位置描述问题,给出并证明了支撑点位置的计算公式,进而讨论了支撑点位置的极限问题。     

神经网络方法在胃收缩识别中的应用

胃收缩运动在消化过程中起着重要作用．传统的测量胃运动的方法是侵 袭性的．本文提出一种运用人工神经网络由体表胃电图（ｅｌｅｃｔｒｏｇａｓｔｒｏｇｒａｍ） 无损识别胃收缩运动的方法．以５个受试者的胃电图作为训练集，另５个受试 者的胃电图作为测试集．以同时检测的与每段胃电图对应的胃腔内压力记录 作为评价标准，运用经过优化的具有单个隐层的反向传播神经网络，以分段 后的每段胃电图的时－频表征作为网络的输入，实验结果表明：识别胃运动静 止期的准确度达９０呢，识别收缩运动期的准确度达９４％．     

AN INVESTIGATION OF THE RELATION BETWEEN COTTON FIBRE PROPERTIES AND YARN QUALITY BY USING HIGH VOLUME INSTRUMENT(HVI)SYSTEM

The objective of this paper is to establish reliable prediction equations relating cotton fibreproperties measured by HVI system and yarn quality,A useful statistical method is adopted for de-veloping a multiple regression model interpreting the relation between the data of Spinlab HVIfibre properties and quality parameters of yarn STQ (Strength Tex Quotient).The percent relativecontribution of a fibre property with respect of STQ is also assessed.The results show that the totalcontribution of the HVI measured fibre properties can account for 77.4% of known variation ofyarn STQ.The main feature of the approach is its flexibility in accommodating all fibre properties.The examination of regression equation showed that it could be well applied to predict STQ ofyarns spun from the same spinning system,but,for different spinning systems and also for yarns ofdifferent linear density,modification of the equation would be needed.     

原油中水滴电分散的研究

原油中的水滴在高压直流电场中被电场力分散成小液滴。通过测定小液滴的平均粒径和原油中被分散的水量,发现水滴的电分散程度与温度和电场强度的变化有密切关系。温度改变原油性质来影响水滴的变形断裂,其中粘性阻力起主导作用。电场强度会明显影响水滴所受的电场力。在80℃下,场强1500V/cm时有10%以上的水滴被分散,到场强5 000V/cm时则达到40%以上。场强超过7 000V/cm以后分散作用的增强逐步减弱。     

关于群环的广义半理想

得到了一个群环RG包含广义左半理想的充要条件。     

MAP kinases in plant signal transduction

Mitogen-activated protein kinase (MAPK) pathways are modules involved in the transduction of extracellular signals to intracellular targets in all eukaryotes. Distinct MAPK pathways are regulated by different extracellular stimuli and are implicated in a wide variety of biological processes. In plants there is evidence for MAPKs playing a role in the signaling of abiotic stresses, pathogens and plant hormones. The large number and divergence of plant MAPKs indicates that this ancient mechanism of bioinformatics is extensively used in plants and may provide a new molecular handle on old questions.     

Evolution of bacterial pathogenesis

The evolution of bacteria is associated with continuous generation of novel genetic variants. The major driving forces in this process are point mutations, genetic rearrangements, and horizontal gene transfer. A large number of human and animal bacterial pathogens have evolved the capacity to produce virulence factors that are directly involved in infection and disease. Additionally, many bacteria express resistance traits against antibiotics. Both virulence factors and resistance determinants are subject to intrastrain genetic and phenotypic variation. They are often encoded on unstable DNA regions. Thus, they can be readily transferred to bacteria of the same species or even to non-related prokaryotes. This review article focuses on the main mechanisms of bacterial microevolution responsible for the rapid emergence of variants with novel virulence and resistance properties. In addition, processes of macroevolution are described with special emphasis on gene transfer and fixation of adaptive mutations in the genome of pathogens.     

Signalling via caveolin: involvement in the cross-talk between phosphoinositolglycans and insulin

In recent years, a number of cross-talk systems have been identified which feed into the insulin signalling cascade at the level of insulin receptor substrate (IRS) tyrosine phosphorylation, e.g., receptor and non-receptor tyrosine kinases and G-protein-coupled receptors. At the molecular level, a number of negative modulator and feedback systems somehow interacting with the beta-subunit (catecholamine-, phorbolester-, or tumor necrosis factor-alpha-induced serine/threonine phosphorylation, carboxy-terminal trimming by a thiol-dependent protease, association of inhibitory/regulatory proteins such as RAD, PC1, PED, alpha2-HS-glycoprotein) have been identified as candidate mechanisms for the impairment of insulin receptor function by elevations in the activity and/or amount of the corresponding modification enzymes/inhibitors. Both decreased responsiveness and sensitivity of the insulin receptor beta-subunit for insulin-induced tyrosine autophosphorylation have been demonstrated in several cellular and animal models of metabolic insulin resistance as well as in the adipose tissue and skeletal muscle of diabetic patients and obese Pima Indians compared to non-obese subjects. Therefore, induction of the insulin signalling cascade by bypassing the defective insulin receptor kinase may be useful for the therapy of non-insulin dependent diabetes mellitus. During the past two decades, phosphoinositolglycans (PIGs) of various origin have been demonstrated to exert potent insulin-mimetic metabolic effects upon incubation with cultured or isolated muscle and adipose cells. However, it remained to be elucidated whether these compounds actually manage to trigger insulin signalling and if so at which level of hierarchy within the signalling cascade the site of interference is located. Recent studies using isolated rat adipocytes and chemically synthesized PIG compounds point to IRS1/3 tyrosine phosphorylation by p59Lyn kinase as the site of cross-talk, the negative regulation of which by interaction with caveolin is apparently abrogated by PIG. This putative mechanism is thus compatible with the recently formulated caveolin signalling hypothesis, the supporting data for which are reviewed here. Though we have not obtained experimental evidence for the involvement of PIG in physiological insulin action, the potential cross-talk between insulin and PIG signalling, including the caveolae/detergent-insoluble glycolipid-enriched rafts as the compartments where the corresponding signalling components are concentrated, thus represent novel targets for signal transduction therapy.     

Proteasomes in apoptosis: villains or guardians?

The proteasome (multicatalytic proteinase complex, prosome) is a major cytoplasmic proteolytic enzyme, responsible for degradation of the vast majority of intracellular proteins. Proteins degraded by the proteasome are usually tagged with multiple ubiquitin moieties, conjugated to the substrates by a complicated cascade of enzymes. Over the last years, evidence has accumulated that changes in the expression and activity of the different components of the ubiquitin-proteasome system occur during apoptosis. Proteasome inhibitors have been used to induce apoptosis in various cell types, whereas in others, these compounds were able to prevent apoptosis induced by different stimuli. The proteasome mediated step(s) in apoptosis is located upstream of mitochondrial changes and caspase activation, and can involve in different systems Bcl-2, Jun N-terminal kinase, heat shock proteins, Myc, p53, polyamines and other factors.     

Chemotherapy and immunotherapy of malignant glioma: molecular mechanisms and clinical perspectives

Despite the considerable progress in modern tumor therapy, the prognosis for patients with glioblastoma, the most frequent malignant brain tumor, has not been substantially improved. Although cytoreductive surgery and radiotherapy are the mainstays of treatment for malignant glioma at present, novel cytotoxic drugs and immunotherapeutic approaches hold great promise as effective weapons against these malignancies. Thus, great efforts are being made to enhance antitumoral efficacy by combining various cytotoxic agents, by novel routes of drug administration, or by combining anticancer drugs and immune modulators. Immunotherapeutic approaches include cytotoxic cytokines, targeted antibodies, and vaccination strategies. However, the success of most of these experimental therapies is prevented by the marked molecular resistance of glioma cells to diverse cytotoxic agents or by glioma-associated immunosuppression. One promising experimental strategy to target glioma is the employment of death ligands such as CD95 (Fas/Apo1) ligand or Apo2 ligand (TRAIL). Specific proapoptotic approaches may overcome many of the obvious obstacles to a satisfactory management of malignant brain tumors. Received 8 March 1999; received after revision 27 May 1999; accepted 14 June 1999